NE

NEA — Seed & Series A VC Firm ($500K–$100.0M Checks)

VC
San Francisco, CAProfile updated November 2026Website

NEA is a Seed, Series A, Series B venture capital firm based in San Francisco, CA investing in Healthcare, Enterprise, Consumer. The firm typically writes $500K–$100.0M checks and has 38 portfolio companies in our records.

Check size
$500K–$100.0M
Portfolio
38 companies on record
Partners
37 listed
AUM
$26B
Stage
Seed, Series A, Series B, Growth
Sectors
Healthcare, Enterprise, Consumer, SaaS, Fintech
HQ
San Francisco, CA

Last verified: 2026-07-18

Stage

Seed, Series A, Series B, Growth

Check Size

$500K – $100.0M

AUM

$25.9B

Portfolio

38+ companies

Team

37 partners

Investor activity
Last known investment: 2026Investments in 2026: 1

About NEA

NEA is a venture capital firm headquartered in San Francisco, CA. The firm invests across seed, series A, series B, and series C+ stages. NEA focuses on the sectors of healthcare, enterprise, consumer, enterprise software, B2B SaaS, fintech, and financial services. Typical check sizes range from $500K to $100.0M.

With $26B in assets under management, NEA maintains an active investment approach in its target sectors. The firm is supported by a team that includes General Partner Liza Landsman, whose focus areas are consumer and fintech, along with Partners Michele Park, Madison Faulkner, Andrew Schoen, Blake Wu, Matthew Mcaviney, and Brad Thawley, Venture Partners Kavita Patel and Hilarie Koplow-McAdams, and Vice President of Talent Emily Baine.

Investment Thesis

New Enterprise Associates - one of the world's largest and most active venture capital firms.

How NEA invests

NEA is a vc firm based in San Francisco, CA. The firm invests at the Seed, Series A, Series B, Growth stages, with a focus on Healthcare, Enterprise, Consumer, SaaS, Fintech.

NEA typically writes checks of $500K–$100.0M per investment, backed by approximately $26B in assets under management.

Investing since at least 2010, NEA has backed 38 companies in our records, including tectora, factory, horizon3ai. Its most recent recorded investment was in 2026, with 1 investment logged in 2026.

Partners & Team

KP

Kavita Patel, MD

Venture Partner

MP

Michele Park, PhD

Partner

MF

Madison Faulkner

Partner

AS

Andrew Schoen

Partner

HK

Hilarie Koplow-McAdams

Venture Partner

LL

Liza Landsman

General Partner

Consumer
Fintech
EB

Emily Baine

Vice President of Talent

BW

Blake Wu

Partner

MM

Matthew Mcaviney

Partner

BT

Brad Thawley

Partner

SH

Shanna Hendriks

Director of Business Development

DL

Danielle Lay

Partner

FB

Forest Baskett

General Partner

LA

Laura Antonelli

Director of Financial Reporting

PC

Philip Chopin

Managing Director, NEA UK

UK
RY

Rick Yang

Partner, Head of Technology

Technology
SG

Scott Gottlieb, MD

Partner

JI

Jeff Immelt

Venture Partner

MN

Mustafa Neemuchwala

Partner

LP

Luke Pappas

Partner

BS

Brooke Seawell

Venture Partner

JB

James Buxton, MD

Principal

AJ

Aaron Jacobson

Partner

AB

Ali Behbahani, MD

Partner, Co-Head of Healthcare

Healthcare
CC

Carmen Chang

Partner, Head of Asia

Asia
MH

Mark Hawkins

Venture Partner

TL

Tiffany Luck

Partner

AS

Alex Sharata

Partner

GP

Greg Papadopoulos, PhD

Venture Partner

LT

Lila Tretikov

Partner, Head of AI Strategy

AI Strategy
MM

Mohamad Makhzoumi

Co-CEO

MM

Matt McAviney, MD

Partner

SS

Scott Sandell

Executive Chairman & Chief Investment Officer

AJ

Arjun Jain

Partner

PW

Paul Walker

Partner, Co-Head of Healthcare

Healthcare
TF

Tony Florence

Co-CEO

EM

Edward Mathers

Partner

Industry Focus

Invests In

Healthcare
Enterprise
Consumer
SaaS
Fintech

Recent Activity

Investment Track Record

NEA has recorded 38 portfolio companies with investments made from 2010 through 2026. The firm has backed early-stage and growth companies across its target sectors. Recent recorded investments include tectora in healthcare and biopharma in 2026, cuspai and factory in technology and enterprise in 2025, and horizon3ai in technology and enterprise at the growth stage in 2025.

Additional recorded investments include corxel in healthcare and life sciences in 2024, elevenlabs in technology and consumer in 2024, metronome and perplexity in 2023, and multiple companies in 2022 such as brale and ledge in fintech, celcuity in healthcare and life sciences at the public/PIPES stage, fizz and kindred in consumer technology, and nexo and revelio in biopharma, life sciences, and healthcare.

Portfolio Companies (38)

2026

TE

tectora

Healthcare, Biopharma·Early

2025

FA

factory

Technology, Enterprise·Early
HO

horizon3ai

Technology, Enterprise·Growth
CU

cuspai

Technology, Enterprise·Early

2024

EL

elevenlabs

Technology, Consumer·Early
CO

corxel

Healthcare, Life Sciences·Seed

2023

ME

metronome

Technology, Enterprise·Early
PE

perplexity

Technology, Consumer·Early

2022

NE

nexo

Biopharma, Life Sciences, Healthcare·Early
CE

celcuity

Healthcare, Life Sciences·Public/PIPES
How to pitch NEA
  • •Raising at Seed, Series A, Series B, Growth? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare, Enterprise, Consumer — the sectors they actively back.
  • •Size your ask to their typical $500K – $100.0M check.
  • •Address your outreach to a specific partner, such as Kavita Patel, MD, Venture Partner.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if NEA is a match for your startup

Upload your pitch deck to see how well you match with NEA and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal